|Articles|July 30, 2015
Video: CFO Simon Dingemans on GSK's Q2 Results
July 30, 2015.
Advertisement
In this video
, GlaxoSmithKline CFO Simon Dingemans relays the company's Q2 2015 results, rhe first since the Novartis transaction closed. Despite a slide in the sales of lung drug Advair and lower profit margins following a business revamp, Dingemans says sales rose during the period and that newly acquired businesses are performing in line with expectations.
http://www.3bnexus.com/portal/video/6hdb24abf34c8cc
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
3
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
